Aviceda Therapeutics Domain Security

Domain security

Domain security posture for Aviceda Therapeutics, probed live across 1 host(s) and 1 registrable domain(s). 1 host(s) serve HTTPS (up to TLSv1.3); 1 advertise HSTS. Email/DNS controls: DNSSEC present, SPF present, DMARC absent.

CompanyBiotechnologyPharmaceuticalsTherapeuticsOphthalmologyClinical TrialsLife Sciences

Transport & Host Security

www.avicedarx.com

HTTPS: yes · TLS: TLSv1.3 · HSTS: yes · cert expires: Sep 11 21:53:50 2026 GMT

Domain (DNS/Email) Security

avicedarx.com

DNSSEC: yes · SPF: yes · DMARC: no · CAA: none

Source

Domain Security

generated: '2026-08-06'
method: probed
source: live DNS/TLS/HTTP probes of apis.yml + OpenAPI hosts
hosts:
- host: www.avicedarx.com
  https: true
  tls_version: TLSv1.3
  cert_expires: Sep 11 21:53:50 2026 GMT
  hsts: true
  hsts_max_age: 31536000
domains:
- domain: avicedarx.com
  dnssec: true
  caa: []
  spf: true
  dmarc: false